AIM
ARK Investment Management’s Castle Biosciences CSTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Hold |
0
| – | – | – | 262 |
|
|
2022
Q2 | – | Sell |
-1,170,111
| Closed | -$52.5M | – | 338 |
|
|
2022
Q1 | $52.5M | Sell |
1,170,111
-43,096
| -4% | -$1.93M | 0.22% | 66 |
|
|
2021
Q4 | $52M | Sell |
1,213,207
-844,660
| -41% | -$36.2M | 0.16% | 84 |
|
|
2021
Q3 | $137M | Sell |
2,057,867
-467,746
| -19% | -$31.1M | 0.33% | 57 |
|
|
2021
Q2 | $185M | Sell |
2,525,613
-71,675
| -3% | -$5.26M | 0.34% | 64 |
|
|
2021
Q1 | $178M | Buy |
2,597,288
+528,696
| +26% | +$36.2M | 0.35% | 68 |
|
|
2020
Q4 | $139M | Buy |
2,068,592
+1,620,867
| +362% | +$109M | 0.37% | 62 |
|
|
2020
Q3 | $23M | Sell |
447,725
-26,045
| -5% | -$1.34M | 0.14% | 84 |
|
|
2020
Q2 | $17.9M | Buy |
473,770
+253,318
| +115% | +$9.55M | 0.19% | 65 |
|
|
2020
Q1 | $6.57M | Buy |
220,452
+14,438
| +7% | +$430K | 0.16% | 68 |
|
|
2019
Q4 | $7.08M | Buy |
206,014
+39,927
| +24% | +$1.37M | 0.18% | 66 |
|
|
2019
Q3 | $3.01M | Buy |
+166,087
| New | +$3.01M | 0.07% | 88 |
|